- Form for non-clinical and clinical studies proposed in a PIP application, Human Medicines, Scientific Guidelines - Medicines for children - Guidance for applicants
- Draft Guideline on clinical investigation of medicinal products in the treatment of diabetes mellitus, Human Medicines, Scientific Guidelines - Clinical Efficacy and Safety
- Overview of comments received on draft guideline on the investigation of bioequivalence, Human Medicines, Scientific Guidelines - Clinical Efficacy and Safety
- Guideline on Clinical Investigation of Medicinal Products used in the treatment of Osteoarthritis, Human Medicines, Scientific Guidelines - Clinical Efficacy and Safety
- Overview of comments received on above draft guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis, Human Medicines, Scientific Guidelines - Clinical Efficacy and Safety
- Concept paper on the need for revision of the points to consider on the Clinical Investigation of Medicinal products other than Nsaids in Rheumatoid Arthritis, Human Medicines, Scientific guidelines - Clinical Efficacy & Safety
January 29, 2010: Guidance for Industry
- Comprehensive List of Guidance Documents
- Guidances CDER is Planning to Develop During Calendar Year 2010
- Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies
More FDA news:
- Center for Drug Evaluation and Research News (CDER)
- Center for Biologics Evaluation and Research News (CBER)